Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|January 14, 2014
Future of drug development: the economics of pharmacogenomicsJohn A Vernon, Keener Hughen, Joseph H GolecPharmacoeconomics|September 14, 2010
Comparative effectiveness regulations and pharmaceutical innovationJohn A Vernon, Joseph H Golec, J Stedman StevensHealth Economics|August 6, 2009
Drug development costs when financial risk is measured using the Fama-French three-factor modelJohn A Vernon, Joseph H Golec, Joseph A DimasiPaediatric Drugs|July 11, 2012
Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislationJohn A Vernon, Scott H Shortenhaus, Mark H Mayer, et al.Health Economics|September 24, 2004
Examining the link between price regulation and pharmaceutical R&D investmentJohn A VernonApplied Health Economics and Health Policy|October 6, 2009
Financial risk of the biotech industry versus the pharmaceutical industryJoseph Golec, John A VernonPharmacoeconomics|July 13, 2010
Financial effects of pharmaceutical price regulation on R&D spending by EU versus US firmsJoseph Golec, John A VernonInquiry : a Journal of Medical Care Organization, Provision and Financing|March 15, 2008
Ownership form and consumer welfare: evidence from the nursing home industryRexford E Santerre, John A VernonHealth Economics|June 24, 2006
The consumer welfare implications of the hospital ownership mix in the US: an exploratory studyRexford E Santerre, John A VernonValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 22, 2006
A primer on dynamic optimization and optimal control in pharmacoeconomicsJohn A Vernon, W Keener HughenPageof 2